https://www.selleckchem.com/pr....oducts/abraxane-nab-
" © 2020 Wiley Periodicals, Inc.OBJECTIVE Recreational legalization of cannabis may influence the medical use by patients. When only medical access was legally available in Canada, 4.3% of rheumatology patients reported use. With the current recreational legalization, we have reexamined the prevalence and characteristics of medical cannabis use in this same rheumatology setting. METHODS Consecutively attending rheumatology patients participated in an onsite survey comprising the following two questionnaires 1) demographi
Curtir
Comentario
Compartilhar
